Clinical trials
Not yet recruiting Phase 3 trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2025 | 1 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
| Charite University, Berlin, Germany | 1 |
| European Group for Research In Schizophrenia | 1 |
| Invero Pharma, Inc. | 1 |
| Michael Mæng | 1 |
| Nordsjaellands Hospital | 1 |
| Susanne Dam Nielsen, MD, DMSc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 2 |
| Bacteriuria | 1 |
| Burkitt Lymphoma | 1 |
| Cognitive Dysfunction | 1 |
| Coronary Artery Disease | 1 |
| Diabetes Mellitus, Type 1 | 1 |
| Hemophilia A | 1 |
| Idiopathic Pulmonary Fibrosis | 1 |
| Infections | 1 |
| Insulin Resistance | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.